IL6 and metabolic syndrome: Additionally, in the environment of dyslipidemia, the secretion of pro-inflammatory cytokines, such as IL-6 is activated, and to counteract this, the secretion of CD-16 monocytes and TNF-alpha is also increased, creating an environment in which the inflammatory response is activated [34,35].